Challenges and opportunities for the Pharmaceutical Benefits Scheme-Reference-Cited by-同舟云学术

Challenges and opportunities for the Pharmaceutical Benefits Scheme

Published:2012-02 Issue:3 Volume:196 Page:153-154
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Clarke Philip M¹

Affiliation:

1. Centre for Health Policy, Programs and Economics, School of Population Health, University of Melbourne, Melbourne, VIC.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja12.10092

Reference10 articles.

1. Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

2. Australian Government and Medicines Australia.Memorandum of understanding. September2010.http://www.pbs.gov.au/industry/useful‐resources/memorandum/MOU‐MA‐Sep2010.pdf(accessed Jan 2012).

3. Australian Government Department of Health and Ageing.National Health (Weighted average disclosed price – main disclosure cycle) Determination 2011 (No. PB 80 of 2011).http://www.comlaw.gov.au/Details/F2011L02702(accessed Jan 2012).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Evolution of Statin Pricing in Australia: Observations of Price Disclosure Effects on Pharmaceutical Benefits Scheme Expenditure;Value in Health Regional Issues;2024-03

2. Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China;INQUIRY: The Journal of Health Care Organization, Provision, and Financing;2023-01

3. Medicine shortages in Australia: causes, impact and management strategies in the community setting;International Journal of Clinical Pharmacy;2016-07-06

4. What Can We Expect from Value-Based Funding of Medicines? A Retrospective Study;PharmacoEconomics;2015-11-26

5. Rising cost of anticancer drugs in Australia;Internal Medicine Journal;2014-05